Immunocore Holdings Plc (IMCR) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Immunocore Holdings Plc  (NASDAQ: IMCR)
 

Immunocore Holdings Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Immunocore Holdings Plc's inventory turnover ratio, the ratio that measures Immunocore Holdings Plc's ability to manage its supply chain, sequentially decreased to 0.67 in the second quarter 2026, but it does not raise any concerns as Immunocore Holdings Plc continue to execute well, and the inventory turnover ratio remains above the average. Immunocore Holdings Plc's average inventory processing period in the Jun 30 2026 quarter, has increased to 545 days, from 507 days, in the Mar 31 2026 quarter.

Within Healthcare sector 342 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1886, from total ranking in the first quarter 2026 at 2088.

IMCR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Immunocore Holdings Plc Market Share?

What is Inventory Turnover Ratio?




IMCR Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 42.8 % 21.3 % 23.8 % 25.17 % 57.6 %
Y / Y Cost of Sales Growth 4.62 % -47.77 % 719.09 % 14.51 % -39.07 %
Inventory Turnover Ratio (TTM) 0.67 0.72 0.83 0.46 0.48
IMCR's Total Ranking # 1886 # 2088 # 1989 # 1993 # 1973
Average inventory processing period 548 508 442 785 766
Seq. Inventory Growth -5.6 % 22.41 % 19.22 % 3.65 % -19.81 %
Seq. Cost of Sales Growth 150.69 % -83.94 % 426.9 % -50.67 % 25.15 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 343
Overall Market # 1886

Inventory Turnover Ratio Statistics
High Average Low
0.83 0.63 0.46
(Dec 31 2025)   (Sep 30 2025)




Financial Statements
Immunocore Holdings Plc's Inventories $ 8 Millions Visit IMCR's Balance sheet
Immunocore Holdings Plc's Cost of Revenues TTM $ 5 Millions Visit IMCR's Income Statement
What are IMCR's Sales? Visit IMCR's Sales by Segment

Other Inventory Turnover Ratios
Immunocore Holdings Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IMCR's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IMCR's Competitors
Inventory Turnover Ratio for IMCR's Suppliers
Inventory Turnover Ratio for IMCR's Customers

You may also want to know
IMCR's Sales Growth Rates IMCR's Pe Price to earnings ratio IMCR's Receivables Turnover Ratio IMCR's Stock Quote
IMCR's Net Income Growth Rates IMCR's Ps Price to Sales ratio IMCR's Sales per Employee IMCR's Asset Turnover Ratio
IMCR's Net Margin IMCR's Pb Price to Book ratio IMCR's Financial Strength Ratios IMCR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Ceribell Inc   1.66 $ 11.159  Millions$ 7  Millions
Procept Biorobotics Corporation  1.65 $ 120.119  Millions$ 73  Millions
Sanuwave Health Inc   1.62 $ 10.421  Millions$ 6  Millions
Bio rad Laboratories Inc   1.62 $ 1,245.200  Millions$ 769  Millions
Innovative Eyewear Inc   1.61 $ 2.634  Millions$ 2  Millions
Pfizer Inc  1.60 $ 17,084.000  Millions$ 10,684  Millions
Capsovision Inc   1.60 $ 5.736  Millions$ 4  Millions
Integra Lifesciences Holdings Corp  1.59 $ 783.084  Millions$ 492  Millions
Ss Innovations International Inc  1.58 $ 28.689  Millions$ 18  Millions
Rapid Micro Biosystems Inc   1.57 $ 29.477  Millions$ 19  Millions
Urogen Pharma Ltd   1.54 $ 17.278  Millions$ 11  Millions
Bausch and Lomb Corp  1.54 $ 1,523.000  Millions$ 989  Millions
Staar Surgical Co  1.53 $ 79.388  Millions$ 52  Millions
Abeona Therapeutics Inc   1.51 $ 8.405  Millions$ 6  Millions
Enovis Corp  1.50 $ 898.682  Millions$ 601  Millions
Axogen inc   1.45 $ 63.909  Millions$ 44  Millions
Cv Sciences Inc   1.45 $ 5.804  Millions$ 4  Millions
Nuwellis Inc   1.43 $ 2.732  Millions$ 2  Millions
Insmed Inc  1.43 $ 188.217  Millions$ 132  Millions
Teleflex Incorporated  1.42 $ 689.171  Millions$ 485  Millions
Cormedix Inc   1.42 $ 45.432  Millions$ 32  Millions
Cumberland Pharmaceuticals Inc   1.41 $ 5.164  Millions$ 4  Millions
Standard Biotools Inc   1.41 $ 28.569  Millions$ 20  Millions
Outset Medical Inc   1.40 $ 67.951  Millions$ 48  Millions
Biocorrx Inc   1.40 $ 0.170  Millions$ 0  Millions
Lensar Inc   1.38 $ 31.126  Millions$ 23  Millions
Arcutis Biotherapeutics Inc   1.35 $ 41.096  Millions$ 30  Millions
Alphatec Holdings Inc   1.32 $ 237.415  Millions$ 179  Millions
Elanco Animal Health Incorporated  1.29 $ 2,241.000  Millions$ 1,733  Millions
Xtant Medical Holdings Inc   1.28 $ 43.701  Millions$ 34  Millions

Date modified: 2026-09-05T15:13:44+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.